A new preventative measure is now available in Atibaia to protect infants from respiratory syncytial virus (RSV), a common illness that can be notably dangerous for newborns. Beginning December 11th, the Atibaia Health Department has begun offering the RSV vaccine to pregnant individuals at or after 28 weeks gestation, aiming to bolster immunity in vulnerable infants under six months old. The vaccine utilizes maternal antibodies to provide crucial protection during a critical period of advancement and is available through the National Immunization Program (PNI).
Pregnant individuals can now receive a vaccine to help protect their babies from respiratory syncytial virus (RSV), a common and potentially serious respiratory illness, particularly for infants. The Atibaia Health Department began offering the RSV vaccine to expectant mothers starting at 28 weeks of gestation on December 11th. This preventative measure aims to bolster infant immunity, especially for those under 6 months old, who are most vulnerable to severe lower respiratory tract infections like bronchiolitis.
RSV is a leading cause of severe respiratory infections in newborns, often leading to complications and hospitalizations. Protecting infants from RSV is a significant public health priority, as their immune systems are still developing.
The vaccine, known as RSV A and B (recombinant), is administered as a single dose during each pregnancy, regardless of the mother’s age. It works by stimulating the production of maternal antibodies, which are then passed on to the baby, providing crucial protection during the first few months of life.
Vaccines are available at Atibaia’s Basic Health Units, according to the regular vaccination schedule of the National Immunization Program (PNI), and will continue to be offered throughout 2026. To receive the vaccine, pregnant individuals should visit a health unit starting at 28 weeks of gestation, bringing a personal identification document, a prenatal card, a supporting medical exam or report from a healthcare professional, and their vaccination record.
Newborns whose mothers are not vaccinated face a higher risk of developing severe illness and complications from RSV. The municipality aims to achieve 80% vaccine coverage among pregnant individuals, expanding protection for both maternal and infant health.
Individuals who are experiencing a fever, have allergies, are immunocompromised, or have coagulation disorders should inform the vaccination center staff before receiving the vaccine. The vaccine is contraindicated only in cases of hypersensitivity to the active substances or any component of the formula. If you have any questions, consult the health team at the unit.
The RSV vaccination program represents another initiative by the Atibaia government focused on prevention, care, and protection from the earliest stages of life.
